We can't find the internet
Attempting to reconnect
32477.1 IP-LS
32477.1 IP-LS
Résumé
A proof of concept study to assess the potential therapeutic effect of AX-8 in animal models of colitis
Textes supplémentaires
Abstract
Significant unmet medical needs remain for the treatment of inflammatory bowel disease (IBD).\nThe suggested project will allow testing AX-8, an agonist of the poorly explored target TRPM8, as a potential IBD therapy, which could benefit patients by ameliorating both inflammation and pain symptoms.
Participants
Michael Scharl
Kontaktperson
michael.scharl@usz.ch
USZ Universitätsspital Zürich Division of Gastroenterology and He Michael Scharl Rämistrasse 100 8091 Zürich ZH CH
Olivier Poirot
Wirtschaftspartner
opoirot@axalbion.com
Axalbion SA Olivier Poirot EPFL Innovationspark Bâtiment C 1015 Lausanne VD CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2019-01-31
- Date de fin
- 2021-07-31
- Coûts totaux approuvés
- CHF 522550.59
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T410 Pharmaceuticals and related technologies 100.0%